baber/WOPTO huggingface dataset:
Patent AU-2651192-A (AU)
Title: Graft for promoting autogenous tissue growth
IPC: A61B17/11
Filed: 1992-09-21
Abstract: Surgical repair of diseased or damaged endogenous connective tissue can be accomplished using a tissue graft formed from a delaminated segment of intestinal tissue. The tissue graft comprises the intestinal tunica submucosa, and basilar mucosa tissue delaminated from the tunica muscularis and the luminal portion of the tunica mucosa. The graft can be conditioned by stretching and formed as a multilayer composition for high tensile strength and resistance to tearing at its points of attachment to existing physiological structures.
Patent AU-2698695-A (AU)
Title: Linear accelerated device
Inventor: MCMURTREY KEVIN D JR
IPC: G11B25/04
Filed: 1995-06-02
Abstract: High density disc drive apparatus that packs a large number of disc drives into a computer cabinet. The disc drives are removably installed in disc cages mounted on shelves of a drawer that slides out the front of the cabinet. A linear actuator drives the drawer and a controller moderates the actuator to ensure smooth start-up and stopping of the drawer so selected disc drives can be replaced during computer operation without disturbing the operation of the remaining disc drives. Built-in pin connectors facilitate bringing I/O and power cables to the disc drives and the desired replacement.
Patent AU-2775397-A (AU)
Title: Cc-type chemokines
Inventor: FORSSMANN WOLF-GEORG
IPC: C12P21/08
Filed: 1997-04-30
Abstract: The CC type chemokines belong to a family of polypeptides which have proven to be mediators of immune reactions, and they have recently attracted attention due to their antiviral activity with respect to HIV. The cloning and molecular characterization of a human tandem gene is disclosed which contains the closely linked coding regions for two new CC type chemokines the sequences of which are highly homologous with that of MIP-1alpha. The transcription of the tandem gene leads to a bicistronic mature transcript which contains the non-overlapping open reading frames for the recently described factor HCC-1 and an as yet unknown CC type chemokine, designated as CC-2. Moreover, alternative splicing of the primary transcript yields at least one additional CC type chemokine, cytokine CC-3. Two functional promoter regions were identified within the tandem gene. The disclosed data provide some basic knowledge about the structure and expression of the new human CC-2/HCC-1 tandem gene and describe a mechanism according to which the coexpression of closely linked genes could be regulated in higher eucaryotes.
Patent AU-2804595-A (AU)
Title: Sprinkler device
Inventor: HARRIS GERALD
IPC: B05B3/04
Filed: 1995-07-04
Abstract: PCT No. PCT/GB95/01585 Sec. 371 Date Apr. 10, 1997 Sec. 102(e) Date Apr. 10, 1997 PCT Filed Jul. 4, 1995 PCT Pub. No. WO96/01153 PCT Pub. Date Jan. 18, 1996Water is supplied under pressure to a sprinkler device which produces one or more laminar flow jets. A high speed rotor intercepts only the boundary layer of the jets in a manner to impact violently upon the boundary layer. This produces a novel mode of operation in which water exits the jet along its length as vapour to form a mist of find droplets.
Patent AU-3025489-A (AU)
Title: Wettable, rigid gas permeable, substantially non-swellable contact lens
Inventor: ROBERTSON J RICHARD
IPC: C08G77/44
Filed: 1989-02-23
Abstract: This invention relates to ophthalmic devices, such as contact lenses and intraocular implants, and particularly contact lenses of a block copolymer containing polysiloxane and polyoxyalkylene oxide units possessing an advantageous blend of desirable properties including a) high oxygen permeability, b) good wettability, c) optical clarity and d) a substantially lack of aqueous swellability in the ocular environment of use. Even the preparation thereof and methods of treating vision defects therewith are disclosed as well as the polymers suitable for these ophthalmic devices.
Patent AU-3268599-A (AU)
Title: Cable
Inventor: BOOTH DAVID
IPC: H01B7/18
Filed: 1999-03-02
Abstract: A cable comprising a stress-bearing matrix extending substantially through the length of the cable; and a plurality of conducting elements extending substantially through the length of the cable, the plurality of said conducting elements being located within and spaced from one another by said stress-bearing matrix, wherein at least one of the plurality of conducting elements is in intimate contact with a low friction liner disposed about the at least one of the plurality of conducting elements and the at least one of the conducting elements is longitudinally movable relative to the stress-bearing matrix.
Patent AU-3307589-A (AU)
Title: Method of preventing aids transmission resulting from blood transfusions
IPC: A61L2/00
Filed: 1989-04-17
Abstract: Quaternary ammonium salts such as the benzalkonium chlorides and cetylpyridinium chloride can prevent the transmission of AIDS-causing virus through blood transfusions and through the use of blood products prepared using the blood of an AIDS infected individual.
Patent AU-3319193-A (AU)
Title: High performance, durable, low-E glass and method of making same
Inventor: LINGLE PHILIP J
IPC: C23C14/18
Filed: 1993-02-19
Abstract: A high performance, durable, low-E glass exhibiting about 80% or more visible transmittance, a hemispherical emissivity (Eh) of about 0.13 or less, and a normal emissivity (En) of about 0.10 or less is formed by sputter-coating a layer system on the glass substrate which comprises an undercoat and overcoat of Si3N4, at least one silver layer, and at least two sandwiching layers of a nickel or nickel alloy, preferably with the nickel alloy being nichrome, and the chromium being in the form of a nitride thereof. <IMAGE>
Patent AU-3342497-A (AU)
Title: Injection hose and method for the production thereof
Inventor: BLEIBLER ALEXANDER
IPC: E04B1/68
Filed: 1997-06-21
Abstract: An injection hose intended for sealing expansion joint in concrete structures. The hose is in the form a continuous hollow extrusion (12), made of elastic, flexible material, with a continuous longitudinal bore (10) and at least one longitudinal groove (16). The groove (16) is connected to the bore (10) by means of apertures (22) in the wall of the extrusion and is fitted with a sealing strip (24), made of compressible, elastic material, which extends over the apertures (22). Production of the hose is made particularly simple and inexpensive by virtue of the fact that the width of the groove openings (26) is less than the diameter of the sealing strip (24) and that the means of holding the sealing strip (24) in place are formed by making undercuts in the side (30) of the groove (16).
Patent AU-3345284-A (AU)
Title: Fiber optic amplifier
Inventor: SHAW HERBERT JOHN
IPC: G02B6/26
Filed: 1984-09-24
Abstract: An amplifier for use with fiber optic systems comprises a neodymium YAG crystal (44, Figs. 9, 12, and 13) placed in series with a signal-carrying optical fiber (12b, 54). The ND:YAG crystal (44) is supplied by the optical fiber (12b, 54, 62) with both the signal to be amplified, and pumping illumination. The pumping illumination is coupled onto the optical fiber (12b, 54, 62) by a multiplexing coupler (10b, 50, 60) which is used to combine the signal to be amplified and illumination from a pumping illumination source (42) onto the single optical fiber (12b, 54, 62). The pumping illumination inverts the neodymium ions within the ND:YAG crystal (44). The signal to be amplified propagates through this crystal (44) to stimulate emission of coherent light from the neodymium ions, resulting in amplification of the signal. Because this arrangement permits the ND:YAG crystal (44) to be end- pumped with pumping illumination, and because the length of the ND:YAG crystal (44) may be substantially greater than the absorption length for the crystal (44) at the wavelength of the pumping illumination, virtually all of the pumping illumination may be absorbed within the ND:YAG crystal (44) and used for amplification of the signal carried by the optical fiber (12b, 54, 62).
Patent AU-3363097-A (AU)
Title: Safety device for a workshop machine
Inventor: KOENDERS ANDREAS ALBERTUS MARI
IPC: F16P3/16
Filed: 1997-07-14
Abstract: A safety device for a workshop machine contains a safety screen which is equipped with a powering device in order to lower the screen before the machine starts to operate. The powering device contains friction rolls on opposite sides of the screen and are coupled to a drive motor. The screen is equipped on both its top side and its bottom side with approach switching apparatus which, when moved, gives off an electric signal to a central processing unit. The central processing unit is capable of controlling the drive motor in accordance with the signals given off by the approach switching apparatus.
Patent AU-3436495-A (AU)
Title: Film-forming coating solution and synthetic resin lens
Inventor: IRYO TAKEAKI
IPC: G02B1/10
Filed: 1995-10-20
Abstract: Disclosed is a film-forming coating solution comprising a matrix and a fine particulate compound oxide composed of oxides of titanium, silicon and zirconium and/or aluminum. This film-forming coating solution can form a colorless and transparent film of high refractive index which is excellent in dyeing property and adhesion to the substrate. Also disclosed is a synthetic resin lens of high refractive index having a film (hard coat film) formed from the film-forming coating solution on the surface. This synthetic resin lens is free from interference fringe and has a reduced thickness.
Patent AU-3513293-A (AU)
Title: Fire retardant entangled polyester nonwoven fabric
Inventor: HUGHES ALFRED J
IPC: D04H1/46
Filed: 1993-03-10
Abstract: An entangled polyester fiber nonwoven fabric with balanced tensile strength properties and with a fire retardancy in both the machine and cross machine directions of greater than 20 secs. when measured in accordance with NFPA Test No. 702. <IMAGE>
Patent AU-3518699-A (AU)
Title: Liquid, radiation-curable composition, especially for producing flexible cured articles by stereolithography
Inventor: MELISARIS ANASTASIOS PANAYIOTI
IPC: G03F7/027
Filed: 1999-03-19
Abstract: The present invention relates to stereolithographic compositions containing an actinic radiation-curable and cationically polymerizable organic substance, a cationic initiator, a radical photoinitiator, and at least one cationic reactive modifier containing at least two reactive groups per molecule or at least one polyether polyol or mixtures thereof. The cationic reactive modifier has at least one chain extension segment with a molecular weight of at least about 100 and not more than about 2,000. The polyether polyol has a molecular weight greater than or equal to about 4,000. The use of the cationically reactive modifiers and polyether polyol modifiers substantially increases the flexibility and toughness of the cured articles without compromising photospeed, accuracy and wetting-recoatability of the compositions. The present invention further relates to a method of producing a cured product, particularly three-dimensional shaped articles by treating the composition described above with actinic radiation.
Patent AU-3534695-A (AU)
Title: A process for removing essentially naphthenic acids from a hydrocarbon oil
Inventor: GRANDE KNUT
IPC: C10G45/08
Filed: 1995-08-29
Abstract: PCT No. PCT/NO95/00142 Sec. 371 Date Feb. 27, 1997 Sec. 102(e) Date Feb. 27, 1997 PCT Filed Aug. 29, 1995 PCT Pub. No. WO96/06899 PCT Pub. Date Mar. 7, 1996A process for removing essentially naphthenic acids from a crude oil which has not previously been fractionated by distillation, or from which only a naphtha fraction has been distilled. The crude oil is hydrogenated at 1-50 bars and 100-300 DEG  C. over a catalyst of the kind used for hydrogenation of atmospheric residue oils. As a catalyst, especially Ni-Mo or Ni-Co deposited on alumina as a carrier material is used.
Patent AU-3560901-A (AU)
Title: Method for analysing irregularities in human locomotion
Inventor: BARREY ERIC
IPC: A61B5/103
Filed: 2001-02-05
Abstract: The invention relates to a method of analysis for human locomotion irregularities. In such method, acceleration measurements obtained during one or more motions controlled at a stabilized gait of a human being are used, through accelerometers measuring on a time base accelerations according to at least one direction, and any locomotion irregularities are analyzed from reference measurements. Such measured accelerations are submitted to at least one wavelet transformation and the resulting wavelet transform is used to detect and/or analyze the irregularities.
Patent AU-3666389-A (AU)
Title: Compound steel work pieces and method for their production
Inventor: KROISENBRUNNGER WALTER
IPC: B29C48/09
Filed: 1989-06-20
Abstract: The invention relates to a composite steel workpiece and a method of manufacturing same, in which a supporting sleeve is provided with at least one clearance, which clearance is provided with a wear-resistant and/or corrosion-resistant lining, which is bonded to the supporting sleeve to form a metal composite. The invention provides that, in particular for forming a twin-screw or multiple- screw barrel for plastics processing, the supporting sleeve, provided with at least one core at the point(s) of the desired clearance(s), is subjected together with the core(s) to a hot forming process at an appropriate temperature, in particular a cross-sectional reduction, the core(s) is (are) given a non-circular cross-sectional shape and the clearance(s) is (are) formed in the core(s).
Patent AU-3702289-A (AU)
Title: Multi-component coating composition comprising an anhydride containing polymer, a glycidyl component and a self- stabilized dispersion resin
Inventor: BARSOTTI ROBERT J
IPC: C09D201/06
Filed: 1989-06-26
Abstract: A coating composition useful for a finish for automobiles and trucks in which the film forming binder contains reactive binder components of about   (a) 25-94% by weight, based on the weight of the binder, of an acrylic polymer having at least two reactive anhydride groups composed of polymerized monomers of an ethylenically unsaturated anhydride and polymerized monomers from the group consisting of alkyl methacrylate, alkyl acrylate and any mixtures thereof, wherein the alkyl groups have 1-8 carbon atoms and the polymer has a weight average molecular weight of about 2,000-50,000; (b) 5-50% by weight, based on the weight of the binder, of a glycidyl component having at least two reactive glycidyl groups; (c) 1-40% by weight, based on the weight of the binder, of a self-stabilized dispersed resin; and the composition contains about 0.1-5% by weight; based on the weight of the binder, of a catalyst.
Patent AU-3766093-A (AU)
Title: Imaging system
Inventor: DAVIES NEIL
IPC: G02B27/22
Filed: 1993-04-01
Abstract: PCT No. PCT/GB93/00682 Sec. 371 Date Sep. 30, 1994 Sec. 102(e) Date Sep. 30, 1994 PCT Filed Apr. 1, 1993 PCT Pub. No. WO93/20473 PCT Pub. Date Oct. 14, 1993There is disclosed an imaging system forming a pseudoscopic image in focus throughout extended depth of field comprising an input relay lens array, a double integral microlens screen having a median plane on to which the input lens array images an object scene and, on the opposite side of the screen and the same distance therefrom as the input array, an output relay lens array similar to the input lens array.
Patent AU-3784899-A (AU)
Title: Methods and apparatus for dynamic smartcard synchronization and personalization
Inventor: HOHLE WILLIAM
IPC: G06Q20/34
Filed: 1999-05-04
Abstract: A system generally for personalizing and synchronizing smartcard data in the context of a distributed transaction system is disclosed. A dynamic smartcard synchronization system comprises access points configured to initiate a transaction in conjunction with a smartcard, an enterprise data collection unit, and a card object database update system. An exemplary dynamic synchronization system (DSS) preferably comprises various smartcard access points, a secure support client server, a card object database update system (CODUS), one or more enterprise data synchronization interfaces (EDSI), an update logic system, one or more enterprise data collection units (EDCUs), and one or more smartcard access points configured to interoperably accept and interface with smartcards. In an exemplary embodiment, DSS comprises a personalization system and an account maintenance system configured to communicate with CODUS. Personalization of multi-function smartcards is accomplished using a security server configured to generate and/or retrieve cryptographic key information from multiple enterprise key systems during the final phase of the smartcard issuance process.
Patent AU-3818989-A (AU)
Title: The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
Inventor: ENGLERT HEINRICH CHRISTIAN
IPC: A61K31/425
Filed: 1989-07-18
Abstract: The use of 3,4-dihydro-2H-benzo[b]pyrans of the formula I <IMAGE>  in which   R<1> is H, OH, (C1-C2)-alkoxy, (C1-C2)-alkyl or NR<4>R<5>, where R<4> and R<5> are identical or different and are H, (C1-C2)-alkyl or (C1-C3)-alkylcarbonyl, R<2> and R<3> are identical or different and are alkyl with 1-4 C atoms, Ar is an aromatic or heteroaromatic system which is unsubstituted or substituted by 1 to 3 identical or different radicals (C1-C2)-alkyl, (C1-C2)-alkoxy, halogen, trifluoromethyl, CN, NO2, CO-(C1-C2)-alkyl or SOm-(C1-C2)-alkyl with m = 1 or 2,   n is 1 or 2, X is a chain (CH2)r which can be interrupted by a heteroatom O, S or NR<6> where R<6> is H or (C1-C4)-alkyl and r is the numbers 2, 3, 4 or 5, for the production of a medicament for urinary tract disorders.
Patent AU-4043597-A (AU)
Title: Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
Inventor: GAST MICHAEL JAY
IPC: A61K31/565
Filed: 1997-07-23
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for 23-25 consecutive days, a first phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol for 9-13 days beginning on day 1 of the menstrual cycle, wherein the same dosage of the progestin and estrogen combination is administered in each of the 9-13 days, and a second phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 11-15 days beginning on the day immediately following the last day of administration of the first phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 11-15 days, provided that the daily dosage of second phase progestin is greater than the daily dosage of the first phase progestin and that the daily dosage of the second phase estrogen is greater than or equal to the daily dosage of the first phase estrogen.
Patent AU-4049700-A (AU)
Title: Human neurogenin 3-encoding nucleotide sequences
Inventor: GERMAN MICHAEL S
IPC: C12N5/074
Filed: 2000-03-28
Abstract: The present invention features a human neurogenin3 (Ngn3) polypeptide and nucleotide sequences encoding Ngn3 polypeptides. In a particular aspect, the polynucleotide is the nucleotide sequence of SEQ ID NO:1. In addition, the invention features isolated nucleic acid sequence comprising an Ngn3 promoter, as well as a polynucleotide sequences that hybridize under stringent conditions to SEQ ID NO:1. In related aspects the invention features expression vectors and host cells comprising polynucleotides that encode a human Ngn3 polypeptide. The present invention also relates to antibodies that bind specifically to a human Ngn3 polypeptide, methods for producing human Ngn3 polypeptides, methods for identifying  beta -cell precursor cells expressing Ngn3, methods for using the Ngn3 gene and the Ngn3 polypeptide to alter cellular differentiation in culture or in vivo to produce new  beta -cells to treat patients with diabetes mellitus, and identification of individuals at risk for diabetes by detecting alteration in Ngn3 coding and regulatory sequences and Ngn3 expression levels.
Patent AU-4105600-A (AU)
Title: Therapy and use of compounds in therapy
Inventor: ANKER STEFAN
IPC: A61K31/575
Filed: 2000-03-09
Abstract: A method of treating, preventing or ameliorating chronic heart failure or acute heart failure in a patient the method comprising administering to the patient an effective amount of: a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule, for example LPS binding protein, BPI, lipoproteins, bile acids or an antibody capable of binding LPS, a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule or bacterium in the gut, for example charcoal, a bile acid or Fuller's earth, an antibacterial agent that is substantially active in the gut, an agent that is able to inhibit the response by a cell to endotoxin (lipopolysaccharide; LPS), an agent that may form a barrier or that otherwise impedes translocation of bacteria or endotoxin (LPS) from the gut into the patient's circulation. A method of treating, preventing or ameliorating endotoxin-mediated immune activation in acute or chronic heart failure in a patient the method comprising administering to the patient an effective amount of: a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule, for example LPS binding protein, BPI, lipoproteins, bile acids or an antibody capable of binding LPS, a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule or bacterium in the gut, for example charcoal, a bile acid or Fuller's earth, an antibacterial agent that is substantially active in the gut, an agent that is able to inhibit the response by a cell to endotoxin (lipopolysaccharide; LPS), an agent that may form a barrier or that otherwise impedes translocation of bacteria or endotoxin (LPS) from the gut into the patient's circulation.
Patent AU-4174496-A (AU)
Title: Silylation process
Inventor: CENTELLAS VICTOR
IPC: C07F7/18
Filed: 1995-11-20
Abstract: PCT No. PCT/EP95/04562 Sec. 371 Date Jul. 25, 1997 Sec. 102(e) Date Jul. 25, 1997 PCT Filed Nov. 2, 1995 PCT Pub. No. WO96/16067 PCT Pub. Date May 30, 1996A process for the silylation of 6-aminopenicillanic acid or 7-amino-desacetoxy-cephalosporanic acid by silylation in certain carboxylic acid esters and its use in the production of 6-alpha-aminoacyl-penicillins and 7-alpha-aminoacyl-desacetoxy-cephalosporins.
Patent AU-4185996-A (AU)
Title: Hemolysis prevention by surfactants and emulsions
Inventor: HARRISON TIMOTHY
IPC: A61K47/26
Filed: 1995-12-15
Abstract: PCT No. PCT/GB95/02936 Sec. 371 Date Jun. 20, 1997 Sec. 102(e) Date Jun. 20, 1997 PCT Filed Dec. 15, 1995 PCT Pub. No. WO96/19970 PCT Pub. Date Jul. 4, 1996The present invention relates to the use of a non-ionic surface-active agent or an emulsion for the reduction of the hemolytic effects of an amphiphilic compound. There is also provided a method for reducing the hemolytic effects of an amphiphilic compound which comprises formulating said compound with a non-ionic surface-active agent or in the form of an emulsion.
Patent AU-4210000-A (AU)
Title: Laser lens cleaner
Inventor: ESAREY GRAEME D
IPC: G11B7/12
Filed: 2000-04-07
Abstract: A lens cleaner (10) includes brushes (12) extending out of its bottom side and a conductive label (14) on its top side. The brushes (12) sweep the optical lens (16) of a disc player (18) during rotation of the lens cleaner (10). In addition, the conductive label (12) can be touched by a user's finger (F) so as to discharge static from the disc player (18) through the brushes (12) and the lens cleaner (10) and out of the disc player (18).